Overview
Benign fibrohistiocytic neoplasms are non-malignant tumors characterized by the proliferation of fibrohistiocytic cells, often presenting as well-demarcated masses without metastatic potential 2.Diagnosis
Histopathological examination is essential for diagnosis, typically revealing characteristic fibrohistiocytic morphology 2.
Immunohistochemical staining may aid in confirming the diagnosis by highlighting specific markers associated with fibrohistiocytes 2.
Telepathology can facilitate expert consultation in morphologically challenging cases, improving diagnostic accuracy 2.Management
Surgical excision is the primary treatment, aiming for complete removal with clear margins 2.
Adjuvant therapies are generally not required due to the benign nature of these neoplasms 2.
Follow-up imaging or biopsies may be considered based on surgical margins and clinical suspicion 2.Special Populations
No specific guidelines provided in the abstracts regarding management in pregnancy, pediatrics, elderly, or patients with comorbidities 12.Key Recommendations
Utilize telepathology for expert consultation in diagnostically challenging fibrohistiocytic neoplasms to enhance diagnostic reliability (Evidence: Moderate) 2.
Perform complete surgical excision with adequate margins as the mainstay of treatment for benign fibrohistiocytic neoplasms (Evidence: Expert opinion) 2.
Routine adjuvant therapies are not indicated for benign fibrohistiocytic neoplasms (Evidence: Expert opinion) 2.References
1 Bamford WM, Rogers N, Kassam M, Rashbass J, Furness PN. The development and evaluation of the UK national telepathology network. Histopathology 2003. link
2 Kayser K, Fritz P, Drlicek M, Rahn W. Expert consultation by use of telepathology--the Heidelberg experiences. Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology 1995. link